Sort by

Date

Institutional score

Impact

Patients

List order

Sort

Categories

Studies

15278 Unclassified

7294 Research

5662 Reviews

4081 Case Reports

3168 Advanced Trials

1561 Early Trials

1405 Other Trials

278 Meta-Analysis

Guidelines

102 Guidelines

35 Cochrane

23 Consensuses

Congresses

4637 Abstracts

1

Research

Integrative molecular concept modeling of prostate cancer progression.

Tomlins Scott A, Mehra Rohit, Rhodes Daniel R, Cao Xuhong, Wang Lei ...

Nature genetics Vol 39(1)

Read

Date 01 Jan 2007

Institutional score
0.00
Impact
2459.31

Add to library

Add to library

Select a folder

Create a new folder +

Cancel

Date 01 Jan 2007

Institutional score
0.00
Impact
2459.31
2

Research

Projecting the performance of risk prediction based on polygenic analyses of genome-wide association studies.

Chatterjee Nilanjan, Wheeler Bill, Sampson Joshua, Hartge Patricia, Chanock Stephen J ...

Nature genetics Vol 45(4)

Read

Date 01 Apr 2013

Institutional score
743.80
Impact
2459.31

Add to library

Add to library

Select a folder

Create a new folder +

Cancel

Date 01 Apr 2013

Institutional score
743.80
Impact
2459.31
3

Research

The effect of nafarelin acetate, a luteinizing-hormone-releasing hormone agonist, on benign prostatic hyperplasia.

Peters C A, Walsh P C

The New England journal of medicine Vol 317(10)

Read

Date 03 Sep 1987

Institutional score
0.00
Impact
1998.19

Add to library

Add to library

Select a folder

Create a new folder +

Cancel

Date 03 Sep 1987

Institutional score
0.00
Impact
1998.19
4

Research

Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia.

Roos N P, Wennberg J E, Malenka D J, Fisher E S, McPherson K ...

The New England journal of medicine Vol 320(17)

Read

Date 27 Apr 1989

Institutional score
16.94
Impact
1998.19

Add to library

Add to library

Select a folder

Create a new folder +

Cancel

Date 27 Apr 1989

Institutional score
16.94
Impact
1998.19
5

Research

Detection of prostatic cancer by solid-phase radioimmunoassay of serum prostatic acid phosphatase.

Foti A G, Cooper J F, Herschman H, Malvaez R R

The New England journal of medicine Vol 297(25)

Read

Date 22 Dec 1977

Institutional score
0.00
Impact
1998.19

Add to library

Add to library

Select a folder

Create a new folder +

Cancel

Date 22 Dec 1977

Institutional score
0.00
Impact
1998.19
6

Research

Expression of ras oncogene p21 in prostate cancer.

Viola M V, Fromowitz F, Oravez S, Deb S, Finkel G ...

The New England journal of medicine Vol 314(3)

Read

Date 16 Jan 1986

Institutional score
0.00
Impact
1998.19

Add to library

Add to library

Select a folder

Create a new folder +

Cancel

Date 16 Jan 1986

Institutional score
0.00
Impact
1998.19
7

Research

Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.

Stamey T A, Yang N, Hay A R, McNeal J E, Freiha F S ...

The New England journal of medicine Vol 317(15)

Read

Date 08 Oct 1987

Institutional score
0.00
Impact
1998.19

Add to library

Add to library

Select a folder

Create a new folder +

Cancel

Date 08 Oct 1987

Institutional score
0.00
Impact
1998.19
8

Research

Dutasteride and prostate cancer.

Garattini Silvio, Bertele' Vittorio

The New England journal of medicine Vol 363(8)

Read

Date 19 Aug 2010

Institutional score
0.00
Impact
1998.19

Add to library

Add to library

Select a folder

Create a new folder +

Cancel

Date 19 Aug 2010

Institutional score
0.00
Impact
1998.19
9

Research

Detection of malignant tumors. Water-suppressed proton nuclear magnetic resonance spectroscopy of plasma.

Fossel E T, Carr J M, McDonagh J

The New England journal of medicine Vol 315(22)

Read

Date 27 Nov 1986

Institutional score
0.00
Impact
1998.19

Add to library

Add to library

Select a folder

Create a new folder +

Cancel

Date 27 Nov 1986

Institutional score
0.00
Impact
1998.19
10

Research

Lack of efficacy of water-suppressed proton nuclear magnetic resonance spectroscopy of plasma for the detection of malignant tumors.

Okunieff P, Zietman A, Kahn J, Singer S, Neuringer L J ...

The New England journal of medicine Vol 322(14)

Read

Date 05 Apr 1990

Institutional score
140.34
Impact
1998.19

Add to library

Add to library

Select a folder

Create a new folder +

Cancel

Date 05 Apr 1990

Institutional score
140.34
Impact
1998.19

View

per page

Page

1

2

3

4

5

6

7

8

9

10

Last